With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced its custom nucleic acid delivery particle synthesis services for the advancement of gene therapy, gene editing, vaccines and immunotherapy. These new offerings, such as the synthesis of basic particles, can address the growing need for safe and efficient delivery of gene therapy materials. CD...